v3.26.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2026
Segment Information [Abstract]  
Schedule of Significant Segment Expenses

The following table summarized significant segment expenses for the three months ended March 31, 2026 and 2025:

 

    Lysosomal Storage
Disorders Segment
 
    Three Months Ended
March 31,
 
    2026     2025  
    (In thousands)  
Research and development expenses (excluding stock compensation)   $ (679 )   $ (372 )
General and administrative expenses (excluding stock compensation)     (812 )     (229 )
Stock-based compensation     (467 )     (4,451 )
Other expense – direct listing offering costs     (586 )      
Net loss   $ (2,544 )   $ (5,052 )